Peter Greenleaf's Net Worth
$17.9 Million
Who is Peter Greenleaf?
Peter Greenleaf has an estimated net worth of $17.9 Million. This is based on reported shares across multiple companies, which include EYEGATE PHARMACEUTICALS INC, BIODELIVERY SCIENCES INTERNATIONAL INC, Aurinia Pharmaceuticals Inc., Sucampo Pharmaceuticals, Inc., ANTARES PHARMA, INC., Mast Therapeutics, Inc., Mirna Therapeutics, Inc., Cerecor Inc., and MEDIMMUNE INC /DE.
SEC CIK
Peter Greenleaf's CIK is 0001363683
Past Insider Trading and Trends
2016 was Peter Greenleaf's most active year for acquiring shares with 11 total transactions. Peter Greenleaf's most active month to acquire stocks was the month of February. 2022 was Peter Greenleaf's most active year for disposing of shares, totalling 12 transactions. Peter Greenleaf's most active month to dispose stocks was the month of February. 2016 saw Peter Greenleaf paying a total of $1,370,415.96 for 731,723 shares, this is the most they've acquired in one year. In 2018 Peter Greenleaf cashed out on 1,800,373 shares for a total of $14,350,472.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EYEGATE PHARMACEUTICALS INC (KPRX) Snapshot price: $3.61
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIODELIVERY SCIENCES INTERNATIONAL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -105.03K |
—
|
—
|
0
|
Mar 22
| |||
Form 4
| +10.81% | 10.25K |
—
|
—
| 105.03K |
Jan 27
| |||
Form 4
| +58.54% | 35K |
—
|
—
| 94.79K |
Aug 6
| |||
Form 4
| +141.20% | 35K |
—
|
—
| 59.79K |
Aug 7
| |||
Form 4
| +580.24% | 21.14K |
—
|
—
| 24.79K |
Aug 13
| |||
Form 4
|
∞
| 3.64K |
—
|
—
| 3.64K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aurinia Pharmaceuticals Inc. (AUPH) Snapshot price: $7.4
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.70% | -126.98K |
$5.60 | -$711,093.60 | 1.52M |
Mar 6
| |||
Form 4
| +66.99% | 661.54K |
—
|
—
| 1.65M |
Feb 20
| |||
Form 4/A
| -3.25% | -33.05K |
$8.78 | -$290,152.66 | 982.67K |
Mar 2
| |||
Form 4
| +182.21% | 634.66K |
$8.94 | -$292,785.00 | 982.97K |
Mar 2
| |||
Form 4
| +140.02% | 19.23K |
$12.01 | -$108,906.68 | 32.97K |
Mar 2
| |||
Form 4
| +61.54% | 5.13K |
$10.71 | $54,891.07 | 13.45K |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sucampo Pharmaceuticals, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -129.73K |
$18.00 | -$2,335,122.00 |
0
|
Feb 13
| |||
Form 4
| +3.70% | 171 |
$9.10 | $1,556.10 | 4.79K |
Dec 31
| |||
Form 4
| +16.63% | 659 |
$9.10 | $5,996.90 | 4.62K |
Sep 30
| |||
Form 4
| +20.46% | 673 |
$8.93 | $6,009.89 | 3.96K |
Jun 30
| |||
Form 4
| +24.21% | 641 |
$9.35 | $5,993.35 | 3.29K |
Mar 31
| |||
Form 4
|
∞
| 125K |
—
|
—
| 125K |
Mar 6
| |||
Form 4
| +5.37% | 135 |
$10.46 | $1,412.10 | 2.65K |
Dec 31
| |||
Form 4
|
—
|
0
|
$11.80 | -$2,018,806.56 | 2.51K |
Nov 28 - Nov 29
| |||
Form 4
| +34.17% | 640 |
$9.38 | $6,003.20 | 2.51K |
Sep 30
| |||
Form 4
| +66.93% | 751 |
$9.32 | $6,999.32 | 1.87K |
Jun 30
| |||
Form 4
| +135.71% | 646 |
$9.29 | $6,001.34 | 1.12K |
Mar 31
| |||
Form 4
|
∞
| 476 |
$14.70 | $6,997.20 | 476 |
Dec 31 - Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
| No matching records found | |||||||||
ANTARES PHARMA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -79.64K |
$5.60 | -$446,012.00 |
0
|
May 24
| |||
Form 4
| +46.97% | 25.45K |
$4.42 | $112,497.84 | 79.64K |
Jun 10
| |||
Form 4
| +126.06% | 30.22K |
$2.73 | $82,500.60 | 54.19K |
Jun 11
| |||
Form 4
|
∞
| 23.97K |
$2.92 | $70,001.16 | 23.97K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||